Oncoclinicas sells 27.49% stake in Saudi joint venture as part of out-of-court restructuring plan

• Oncoclinicas sold its entire 27.49% stake in Saudi joint venture Specialized Medical Treatment Company to Advanced Drug Company for Pharmaceuticals.
• The stake covered 45,000,754 shares; the share purchase agreement was signed on July 31.
• The divestment was framed as part of measures tied to its out-of-court restructuring plan filed on July 13.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein.